Gdf15: an emerging modulator of immunity and a strategy in covid-19 in association with iron metabolism

HIGHLIGHTS

• who: Luc Rochette from the Pathophysiology and Epidemiology of Cerebro-Cardiovascular Diseases Research Unit (PEC2, EA, ), University of Burgundy and FrancheComté, UFR des Sciences de Santé, Dijon, France , Cardiology Unit, Dijon Bourgogne University Hospital, Dijon, France have published the paper: GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism, in the Journal: (JOURNAL)
• what: The aim of the COVID MECH study was to investigate the prognostic value of GDF15 in patients with laboratory-confirmed infection with SARS-CoV-2 and symptoms of COVID-19.
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.